key: cord-0941192-netps4ww authors: Colais, Paola; Cascini, Silvia; Balducci, Maria; Agabiti, Nera; Davoli, Marina; Fusco, Danilo; Calandrini, Enrico; Bargagli, Anna Maria title: Impact of the COVID‐19 pandemic on access to healthcare services amongst patients with multiple sclerosis in the Lazio region, Italy date: 2021-05-14 journal: Eur J Neurol DOI: 10.1111/ene.14879 sha: 685d739ab5b62d56e9d30623c30ba7cb7d3a3a4c doc_id: 941192 cord_uid: netps4ww BACKGROUND AND PURPOSE: Multiple sclerosis (MS) is a complex chronic, autoimmune inflammatory disease involving multidisciplinary assessments and interventions. Access to outpatient specialist and home healthcare services was explored during the pandemic outbreak and the lockdown amongst MS patients in the Lazio region. Adherence to disease‐modifying therapies (DMTs) is also described. METHODS: A population‐based study was conducted using regional healthcare administrative databases. A validated algorithm was used to identify MS cases over the period 2011–2018. The numbers of specialist and home‐based services were compared between 2019 and 2020. The medication possession ratio was used to measure adherence to DMTs. RESULTS: A total of 9380 MS patients were identified (68% women). A decline in the number of outpatient care services between March and June 2020 compared to the previous year was observed, in particular for rehabilitation (−82%), magnetic resonance imaging (−56%) and neurological specialist services (−91%). Important year‐to‐year variations were observed in May and June 2020 in home‐based nursing and medical care (−91%) and motor re‐education services (−74%). Adherence to DMTs was higher in the first 4 months of 2019 compared to the same period of 2020 (67.1% vs. 57.0%). CONCLUSIONS: A notable disruption of rehabilitative therapy and home‐based services as well as in DMT adherence was observed. Since the pandemic is still ongoing and interruption of healthcare services could have a major impact on MS patients, it is necessary to monitor access of MS patients to healthcare resources in order to ensure adequate treatments, including rehabilitative therapies. challenge, as on the one hand they need to address a growing demand for care of COVID-19 patients and on the other they need to maintain continuity of care for patients with chronic diseases or severe acute conditions. Multiple sclerosis (MS) is a progressive, inflammatory, autoimmune, neurodegenerative disease of the central nervous system and the most common cause of non-traumatic neurological disability in young adults [4] . MS patients require to have a regular access to a wide range of medical services (e.g., infusions, physical therapy, homecare assistance, specialist visits), which may be disrupted during the pandemic exposing MS patients to a high risk of acute exacerbations and disease complications. A recent survey on MS patients' management in the USA and Europe during the COVID-19 pandemic [5] found that most individuals did not discontinue their disease-modifying therapy (DMT) but observed a significant disruption of rehabilitative therapies and homecare services. Italy was the first Western country to experience the COVID-19 emergency and one with the most cases and deaths. The first Italian patient was diagnosed in mid-February in Lombardy (northern Italy). The Italian government put the entire country in lockdown, with a gradual reduction of containment measures starting on 4 May. Preliminary data on the impact of the COVID-19 epidemic on the management of MS patients in Italy show a reduction in access to drug therapies, rehabilitation and homecare services [6] . Patients with MS require long-term treatment with DMT to control their disease course. Non-adherence to DMT has been associated with poorer clinical outcomes, including higher relapse rates and disease progression [7] . Individuals with MS receiving long-term treatment with immunotherapies have been hypothesized to be at increased risk of infection and mortality from COVID-19 [8] However, it has also been reported that the proportion of patients at high risk of mortality is below 1% [9] . Additionally, Louapre et al. in their registrybased study observed no association between DMT exposure and COVID-19 severity [10] . Recent reports highlight the importance of maintaining DMTs when indicated during the pandemic associated with patients' follow-up and risk mitigation strategies, especially amongst those treated with immunosuppressive drugs [11] [12] [13] . Due to conflicting evidence of the effect of DMTs on the frequency of SARS-CoV-2 infection and the course of COVID-19, the decision whether to initiate or discontinue or maintain medication is a critical issue for both the patient and the physician. With the recent lockdown and unavoidable changes to healthcare delivery, patients with MS may have had limited access to usual medical services (infusions, physical therapy, occupational therapy and homecare services), because of either unavailability or the fear of SARS-CoV-2 infection. In the Lazio region, health administrative databases are comprehensive and contain highquality information, allowing for region-wide public health monitoring and research [14, 15] . A validated algorithm is used to identify MS cases within healthcare administrative databases, for healthcare planning and monitoring purposes [16] . In 2019, 10,400 individuals affected by MS were identified; amongst those, 5200 resided in the metropolitan area of Rome [17] . The objective of the present study was to evaluate access to outpatient specialist and home healthcare services during the pandemic outbreak and the lockdown amongst MS patients in the Lazio region. The impact of the pandemic on adherence to DMTs is also described. The Department of Epidemiology of the Regional Health Service is the referral centre for epidemiological research in the Lazio region and has full access to anonymized health administrative databases. Data were analysed through a standardized methodology according to the national privacy law. Consent was not necessary because information already collected at the beginning of the study was used and the data were analysed anonymously; individuals cannot be identified directly or through identifiers and results are shown in aggregate form. A population-based retrospective cohort study was conducted using linked healthcare administrative databases of the Lazio region (an Italian region in the central part of the country, including the city of Rome, and with about 6,000,000 inhabitants). Information on hospitalizations, drug prescriptions, co-payment exemption due to severe conditions, outpatient specialist and homecare services is available for everyone registered in the regional Health Care Assistance Registry (approximately 97% of residents). All regional administrative databases include a unique person-based identifier allowing for deterministic record-linkage procedures (description of healthcare administrative databases is given in Appendix S1). A validated case-finding algorithm [16] The numbers of outpatient specialist services provided in 2020 from 1 January to 30 June were compared with those of the same 6-month period in 2019. In particular, the following outpatient services were considered: rehabilitative therapy, magnetic resonance imaging and specialist neurological care services. Moreover, the number of home services (nursing/medical care, home-based motor re-education) provided in the period from January 2020 to September 2020 were All statistical analyses were conducted using SAS, version 9.2. There was also a decrease in homecare services delivery in 2020 compared to 2019 (Figure 3) . Finally, no differences were observed between years in the distribution of adherent patients by type of DMT (Appendix S3). This population-based study shows how the widespread COVID-19 pandemic and the measures adopted to face the emergency severely Some limitations of this study must be highlighted. To identify MS patients, a validated algorithm [16] was applied capturing only cases diagnosed and recorded in administrative databases and accounting for about 85% of the total affected population. Moreover, regional administrative databases, although having an optimal coverage and including high-quality data, miss information on relevant clinical characteristics, such as MS phenotype, disease severity and level of disability. Indeed, record linkage between different databases may help in describing the clinical profile of patients but only if a contact with any service within the regional health systems has occurred (e.g., hospital admission, medication prescriptions). The main strength of this study is its population-based approach, allowing for a comprehensive description of the provision of and access to healthcare services at the regional level. The study relies on good quality administrative data currently used not only for descriptive but also for analytical purposes [26, 27] . It is noteworthy that the timely availability of information coming from administrative databases allows healthcare delivery in the region to be monitored and critical points in the provision of and access to healthcare to be identified in order to implement corrective measures. This aspect is particularly relevant in the current public health emergency due to the COVID-19 pandemic. In conclusion, our data suggest that during the COVID-19 outbreak and lockdown restriction measures there was a notable disruption of rehabilitative therapy and homecare services as well as in DMT adherence amongst MS patients residing in the Lazio region. Since the pandemic is still ongoing and interruption of healthcare services could have downstream consequences for MS-related outcomes, there is a need to monitor access of MS patients to healthcare resources and to eventually reorganize services in order to ensure adequate treatments, including rehabilitative therapies. The authors declare that there are no conflicts of interest. project administration (equal); supervision (lead); validation (equal); writing original draft (lead); writing review and editing (lead). The Department of Epidemiology of Lazio Regional Health Service is the regional referral centre for epidemiological research and has full access to anonymized health information systems. Consent was not necessary because the authors used data already collected at the beginning of the study and the data were analysed anonymously through a standardized methodology according to the national pri- COVID-19 significantly impacts health services for noncommunicable diseases Information note on COVID-19 and noncommunicable diseases The impact of COVID-19 on chronic care according to providers: a qualitative study among primary care practices in Belgium Multiple Sclerosis International Federation (MSIF) Multiple sclerosis management during the COVID-19 pandemic Impact of the COVID-19 pandemic on persons with multiple sclerosis: early findings from a survey on disruptions in care and self-reported outcomes Comprehensive systematic review summary: disease-modifying therapies for adults with multiple sclerosis: report of the guideline development, dissemination, and implementation subcommittee of the Infection risks among patients with multiple sclerosis treated with fingolimod, natalizumab, rituximab, and injectable therapies Multiple sclerosis and COVID-19: how many are at risk? Clinical characteristics and outcomes in patients with coronavirus disease 2019 and multiple sclerosis Impact of diseasemodifying drugs on the severity of COVID-19 infection in multiple sclerosis patients Multiple sclerosis disease-modifying therapy and the COVID-19 pandemic: implications on the risk of infection and future vaccination COVID-19 outcomes in MS: observational study of early experience from NYU Multiple Sclerosis Comprehensive Care Center Identifying relapses in multiple sclerosis patients through administrative data: a validation study in the Lazio region Survival and factors predicting mortality after major and minor lower-extremity amputations among patients with diabetes: a population-based study using health information systems Prevalence of multiple sclerosis in the Lazio region, Italy: use of an algorithm based on health information systems Impact of COVID-19 on people with physical disabilities: a rapid review Neurorehabilitation scientific panel of the European Academy of Neurology-EAN. Disability through COVID-19 pandemic: neurorehabilitation cannot wait Impact of COVID-19 on U.S. and Canadian neurologists' therapeutic approach to multiple sclerosis: a survey of knowledge, attitudes, and practices Impact of the COVID-19 pandemic on the health care of >1,000 people living with multiple sclerosis: a cross-sectional study An Italian neurology outpatient clinic facing SARS-CoV-2 pandemic: data from 2,167 patients COVID-19 and multiple sclerosis: predisposition and precautions in treatment ABN guidance on the use of disease-modifying therapies in multiple sclerosis in response to the threat of a coronavirus epidemic Disease-modifying therapies during the COVID-19 outbreak: a narrative review of international and national recommendations Determinants of antipsychotic drugs prescription among community-living older adults with dementia: a population-based study using health information systems in the Lazio region. Italy Inhaled corticosteroid use in chronic obstructive pulmonary disease and risk of pneumonia: a nested case-control population-based study in Lazio (Italy)-the OUTPUL study Additional supporting information may be found online in the Supporting Information section.